Skip to Main Content

Paper Details

Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging?
0
2021
Genitourinary Cancer, Metastatic Castration-Resistant Prostate Cancer, PATIENTS, PSA, Patients, Prostate-Specific Antigen, Prostate-specific antigen, genitourinary cancer, mCRPC, metastatic castration-resistant prostate cancer, patient, patients, prostate cancer
Author NameAffiliation
Matthew D GalskyThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
William K OhThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 2

Datasets

Release 1.2